½ÃÀ庸°í¼­
»óǰÄÚµå
1707347

¼¼°èÀÇ Àü±â°æ·Ã¿ä¹ý ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Global Electroconvulsive Therapy Market, By Product Type, By Application, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Àü ¼¼°è Àü±â°æ·Ã¿ä¹ý ½ÃÀå ±Ô¸ð´Â 2025³â¿¡ 1,790¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç 2032³â¿¡´Â 2,180¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç 2025³âºÎÅÍ 2032³â±îÁö 2.9%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 1,790¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR: 2.90% 2032³â °¡Ä¡ ¿¹Ãø 2,180¸¸ ´Þ·¯
±×¸². Àü±â°æ·Ã¿ä¹ý ¼¼°è ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2025³â
Global Electroconvulsive Therapy Market-IMG1

Àü±â°æ·Ã¿ä¹ý(ECT)Àº ´Ù¸¥ Ä¡·á¹ý¿¡ ¹ÝÀÀÇÏÁö ¾Ê´Â ÁßÁõ ¿ì¿ïÁõÀ̳ª ¾ç±Ø¼º Àå¾Ö ȯÀÚ¿¡°Ô °¡Àå ¸¹ÀÌ »ç¿ëµÇ´Â Ä¡·á¹ýÀÔ´Ï´Ù. ȯÀÚ¿¡°Ô ¸¶ÃëÇÑ »óÅ¿¡¼­ ³ú¿¡ ªÀº ½Ã°£ µ¿¾È Àü±â ÀÚ±ØÀ» °¡ÇÕ´Ï´Ù. Ãʱ⠻ç¿ë¿¡´Â ¿À¸íÀÌ ÀÖ¾úÁö¸¸, ECT´Â Å©°Ô ¹ßÀüÇÏ¿© ƯÁ¤ Á¤½Å Áúȯ¿¡ ´ëÇÑ ¾ÈÀüÇϰí È¿°úÀûÀÎ Ä¡·á¹ýÀ¸·Î ¿©°ÜÁö°í ÀÖÀ¸¸ç, 1930³â´ë¿¡ óÀ½ µµÀÔµÈ ÀÌ·¡·Î ±â¼úÀûÀ¸·Î³ª ¾ÈÀü Ãø¸é¿¡¼­ ¸¹Àº °³¼±ÀÌ ÀÌ·ç¾îÁ³½À´Ï´Ù. Çö´ë Áø·á¿¡¼­ ȯÀÚ´Â ½Ã¼ú Àü¿¡ ±ÙÀ° ÀÌ¿ÏÁ¦¸¦ Åõ¿©Çϰí Àü½Å ¸¶Ã븦 ÇÕ´Ï´Ù. µÎÇÇÀÇ Æ¯Á¤ ºÎÀ§¿¡ Àü±ØÀ» ºÎÂøÇϰí Á¦¾îµÈ Àü·ù¸¦ ³ú¿¡ È帣°Ô ÇÏ¿© ªÀº ½Ã°£ µ¿¾È ¹ßÀÛÀ» ÀÏÀ¸Åµ´Ï´Ù. ECTÀÇ ÀÛ¿ë ±âÀüÀº ¾ÆÁ÷ ¿ÏÀüÈ÷ ¹àÇôÁöÁö ¾Ê¾ÒÁö¸¸, ƯÁ¤ Á¤½Å ÁúȯÀÇ Áõ»óÀ» ºü¸£°Ô ȸº¹½ÃŰ´Â ³ú È­ÇÐÀû º¯È­¸¦ ÀÏÀ¸Å°´Â °ÍÀ¸·Î »ý°¢µË´Ï´Ù. Ä¡·á¸¦ ÇÕ´Ï´Ù. ´Ü±âÀûÀÎ ºÎÀÛ¿ëÀ¸·Î´Â ´Ü±â ±â¾ï»ó½Ç, ¹æÇâ°¨°¢ »ó½Ç, Âø¶õ µîÀÌ ÀÖÀ» ¼ö ÀÖÁö¸¸, ´ë°³ ÀϽÃÀûÀÏ »ÓÀ̸ç, ECT´Â ƯÈ÷ ÀÚ»ì À§ÇèÀÌ ³ôÀº ÁßÁõ ¿ì¿ïÁõ ȯÀÚ³ª ¾à¹° Ä¡·á¸¦ °ßµðÁö ¸øÇϰųª ¹ÝÀÀÇÏÁö ¾Ê´Â ȯÀÚ¿¡°Ô´Â »ý¸íÀ» ±¸ÇÒ ¼ö ÀÖ´Â Ä¡·á¹ýÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. Ä¡·á ¿É¼ÇÀ¸·Î¼­ ECT´Â ½ÅÁßÇÏ°Ô °í·ÁµÇ¾î¾ß Çϸç, ȯÀÚ¿Í °¡Á·, Ä¡·áÆÀ °£¿¡ À§Çè°ú ÀÌÀÍ¿¡ ´ëÇÑ ÃæºÐÇÑ ³íÀǰ¡ ÇÊ¿äÇϸç, ECT´Â ȯÀÚÀÇ ¾ÈÀü°ú µ¿ÀǸ¦ º¸ÀåÇϱâ À§ÇØ ¾ö°ÝÇÑ ÀÇ·á Áöħ¿¡ µû¶ó ½ÃÇàµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

Ä¡·á ÀúÇ×¼º ¿ì¿ïÁõ°ú °°Àº Á¤½Å ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¼¼°è Àü±â°æ·Ã¿ä¹ý ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 2020³â Àü ¼¼°èÀûÀ¸·Î 2¾ï 6,400¸¸ ¸í ÀÌ»óÀÌ ¿ì¿ïÁõÀ» ¾Î°í ÀÖÀ¸¸ç, ¸Å³â ¾à 85¸¸ ¸íÀÌ ¿ì¿ïÁõÀ¸·Î »ç¸ÁÇϰí ÀÖ½À´Ï´Ù. ¾çÃø ´Ü½Ã°£ ÆÞ½º ÀÚ±ØÀ» ÅëÇÑ ±â¼úÀûÀ¸·Î Áøº¸ÇÑ ECT ÀåºñÀÇ µµÀÔÀÌ º¸±ÞÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

±×·¯³ª ECT¿¡ µû¸¥ µÎÅë, ¸Þ½º²¨¿ò, Âø¶õ, ±â¾ï»ó½Ç µîÀÇ ºÎÀÛ¿ëÀÌ Å« °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. Ç¥ÀûÈ­ °æµÎ°³ ÀÚ±âÀÚ±ØÀÇ °³¹ßÀº »õ·Î¿î ±âȸÀÔ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ Àü±â°æ·Ã¿ä¹ý ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
  • ¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
  • ȸ»ç ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è Àü±â°æ·Ã¿ä¹ýÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è Àü±â°æ·Ã¿ä¹ý ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è Àü±â°æ·Ã¿ä¹ý ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ÃÖ±Ù µ¿Çâ
  • PEST ºÐ¼®
  • PORTERÀÇ ºÐ¼®
  • ÇÕº´, Àμö ¹× Á¦ÈÞ

Á¦4Àå ¼¼°èÀÇ Àü±â°æ·Ã¿ä¹ý ½ÃÀå - COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • COVID-19 ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
  • °æÁ¦¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ Àü±â°æ·Ã¿ä¹ý ½ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â

  • ÆíÃø Àü±â°æ·Ã¿ä¹ý
  • ¾çÃø Àü±â°æ·Ã¿ä¹ý

Á¦6Àå ¼¼°èÀÇ Àü±â°æ·Ã¿ä¹ý ½ÃÀå, ¿ëµµº°, 2020-2032³â

  • ÁÖ¿ä¿ì¿ïÀå¾Ö(MDD)
  • ¾ç±Ø¼º Àå¾Ö
  • Á¤½ÅºÐ¿­Áõ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ Àü±â°æ·Ã¿ä¹ý ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â

  • º´¿ø°ú Áø·á¼Ò
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ Àü±â°æ·Ã¿ä¹ý ½ÃÀå, Áö¿ªº°, 2020-2032³â

  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • Mecta
    • Ectron
    • Somatics, LLC.
    • Jude Medical(Abbott)

Á¦10Àå ¼½¼Ç

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç ¼Ò°³
ksm 25.05.30

Global Electroconvulsive Therapy Market is estimated to be valued at USD 17.9 Mn in 2025 and is expected to reach USD 21.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 2.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 17.9 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 2.90% 2032 Value Projection: USD 21.8 Mn
Figure. Global Electroconvulsive Therapy Market Share (%), By Region 2025
Global Electroconvulsive Therapy Market - IMG1

Electroconvulsive Therapy (ECT) is a medical treatment most commonly used for patients with severe major depression or bipolar disorder that has not responded to other treatments. It involves a brief electrical stimulation of the brain while the patient is under anesthesia. Despite the stigma associated with its early use, ECT has significantly evolved and is considered a safe and effective intervention for certain psychiatric disorders. It was first introduced in 1930s, and has undergone numerous modifications in terms of both technique and safety. In modern practice, patients are given a muscle relaxant and put under general anesthesia before the procedure. Electrodes are placed at specific sites on the scalp, and a controlled electric current is passed through the brain, which causes a brief seizure. The mechanisms by which ECT works are still not fully understood, but it is believed to cause changes in brain chemistry that can quickly reverse symptoms of certain mental health conditions. ECT is typically administered two to three times a week, for a total of six to twelve treatments. The immediate side effects may include short-term memory loss, disorientation, and confusion, but these are usually transient. ECT can be life-saving, particularly for individuals with severe depression who are at high risk of suicide, or for those who cannot tolerate or do not respond to medication. As a treatment option, ECT must be considered with caution, and thorough discussions between the patient, their family, and the treatment team are necessary to address the risks and benefits. ECT is practiced under stringent medical guidelines to ensure patient safety and consent.

Market Dynamics:

Rising prevalence of mental health disorders such as treatment-resistant depression is a key driver augmenting the growth of global electroconvulsive therapy market. For instance, according to the World Health Organization (WHO), in 2020, more than 264 Mn people worldwide suffered from depression, and approximately 850,000 deaths are depression-related each year. Introduction of technologically advanced ECT devices with bilateral brief-pulse stimulus is further fueling the adoption.

However, side effects that are associated with ECT includes headache, nausea, confusion, and memory loss act as a major restraint. Development of targeted transcranial magnetic stimulation is an emerging opportunity.

Key features of the study:

  • This report provides in-depth analysis of the global electroconvulsive therapy market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global electroconvulsive therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Mecta, Ectron, Somatics, LLC., St.Jude Medical (Abbott), and among others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global electroconvulsive therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global electroconvulsive therapy market

Detailed Segmentation:

  • Global Electroconvulsive Therapy Market, By Product Type
    • Unilateral Electroconvulsive Therapy
    • Bilateral Electroconvulsive Therapy
  • Global Electroconvulsive Therapy Market, By Application
    • Major Depressive Disorder (MDD)
    • Bipolar Disorder
    • Schizophrenia
    • Others
  • Global Electroconvulsive Therapy Market, By End User
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Others
  • Global Electroconvulsive Therapy Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Mecta
    • Ectron
    • Somatics, LLC.
    • Jude Medical (Abbott)
    • Among Others

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Electroconvulsive Therapy Market, By Product Type
    • Global Electroconvulsive Therapy Market, By Application
    • Global Electroconvulsive Therapy Market, By End User
    • Global Electroconvulsive Therapy Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing prevalence of mental disorders
    • Risk of cognitive impairment
    • Advances in ECT devices
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Electroconvulsive Therapy Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Electroconvulsive Therapy Market, By Product Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Unilateral Electroconvulsive Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Bilateral Electroconvulsive Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Electroconvulsive Therapy Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Major Depressive Disorder (MDD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Bipolar Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Schizophrenia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Electroconvulsive Therapy Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals & Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Electroconvulsive Therapy Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profile
    • Mecta
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Ectron
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Somatics, LLC.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Jude Medical (Abbott)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦